Biosimilar Global Market by Type & Data Validation, Analysis and Forecast 2022
ReportsWeb.com published “Biosimilar Global Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, February 16, 2017 ) According to Publisher, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs has experienced robust market growth. Some of the factors which are triggering the market growth include growing incidences of diseases, rising demand for biosimilars drugs owing to their cost effectiveness and increasing demand to limit healthcare expenditures. However, stringent government regulations will affect biosimilars investments.
For more information http://www.reportsweb.com/biosimilar-global-market-outlook-2016-2022 .
Some of the key players in this market include are Mylan, Inc., Dr. Reddy's Laboratories, Amgen Inc., Sandoz International GmbH , Hospira, Inc., Merck KGAA, Celltrion, Inc., Biocon Ltd. , Teva Pharmaceutical Industries Ltd. and Roche Diagnostics.
Products Covered:
- Peptides
- Erythropoietin
- Interferon
- Human Growth Hormone
- Monoclonal Antibodies
- Granulocyte Colony Stimulating Factor (G-CSF)
- Insulin
- Other Products
Technology Covered:
- Bioassay
- Mass Spectrometry
- Nuclear magnetic resonance (NMR) technology
- Recombinant DNA Technology (rDNA technology)
- Western Blotting
- Electrophoresis
- Chromatography
- Monoclonal Antibodies (MAb) Technology
Application Covered:
- Growth Hormone Deficiency
- Chronic and Autoimmune Diseases
- Blood Disorders
- Oncology Diseases
- Other Applications
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564870/sample .
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564870/buying .
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Biosimilar Market, By Product
6 Global Biosimilar Market, By Technology
7 Global Biosimilar Market, By Application
8 Global Biosimilar Market, By Service
9 Global Biosimilar Market, By Geography
10 Key Developments
11 Company Profiling
11.1 Mylan, Inc.
11.2 Dr. Reddy's Laboratories
11.3 Amgen Inc.
11.4 Sandoz International GmbH
11.5 Hospira, Inc.
11.6 Merck KGAA
11.7 Celltrion, Inc.
11.8 Biocon Ltd.
11.9 Teva Pharmaceutical Industries Ltd.
11.10 Roche Diagnostics
11.11 Biogen idec Inc.
11.12 LG Life Sciences
11.13 Synthon Pharmaceuticals, Inc.
11.14 Novartis AG
Purchase Report at http://www.reportsweb.com/buy&RW0001564870/buy/4150 .
For more information http://www.reportsweb.com/biosimilar-global-market-outlook-2016-2022 .
Some of the key players in this market include are Mylan, Inc., Dr. Reddy's Laboratories, Amgen Inc., Sandoz International GmbH , Hospira, Inc., Merck KGAA, Celltrion, Inc., Biocon Ltd. , Teva Pharmaceutical Industries Ltd. and Roche Diagnostics.
Products Covered:
- Peptides
- Erythropoietin
- Interferon
- Human Growth Hormone
- Monoclonal Antibodies
- Granulocyte Colony Stimulating Factor (G-CSF)
- Insulin
- Other Products
Technology Covered:
- Bioassay
- Mass Spectrometry
- Nuclear magnetic resonance (NMR) technology
- Recombinant DNA Technology (rDNA technology)
- Western Blotting
- Electrophoresis
- Chromatography
- Monoclonal Antibodies (MAb) Technology
Application Covered:
- Growth Hormone Deficiency
- Chronic and Autoimmune Diseases
- Blood Disorders
- Oncology Diseases
- Other Applications
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564870/sample .
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564870/buying .
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Biosimilar Market, By Product
6 Global Biosimilar Market, By Technology
7 Global Biosimilar Market, By Application
8 Global Biosimilar Market, By Service
9 Global Biosimilar Market, By Geography
10 Key Developments
11 Company Profiling
11.1 Mylan, Inc.
11.2 Dr. Reddy's Laboratories
11.3 Amgen Inc.
11.4 Sandoz International GmbH
11.5 Hospira, Inc.
11.6 Merck KGAA
11.7 Celltrion, Inc.
11.8 Biocon Ltd.
11.9 Teva Pharmaceutical Industries Ltd.
11.10 Roche Diagnostics
11.11 Biogen idec Inc.
11.12 LG Life Sciences
11.13 Synthon Pharmaceuticals, Inc.
11.14 Novartis AG
Purchase Report at http://www.reportsweb.com/buy&RW0001564870/buy/4150 .
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results